Thyrocare Technologies

THYROCARE

₹ 846.62

- ₹ 16.18

-1.87%

Modeled data

Thyrocare Technologies
Market Sentiment

Timeline	Returns	Volume
Daily	-1.87	23,018
Weekly	-0.00%	4,69,829
Monthly	9.14%	21,13,992

Thyrocare Technologies
Performance

Timeline	Daily	Weekly	Monthly
THYROCARE	-1.87	-0.00%	9.14%
Index	-	-	-
Peer Avg.	-	0.69%	7.74%

*Avg of index constituents

Thyrocare Technologies
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
THYROCARE	25.08	7.87	20.28	34.43	45.83	2.62
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	53.94	8.01	26.27	19.10	24.51	0.38

*Avg of index constituents

Thyrocare Technologies
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	18.73%	41.31%	34.43%	45.83%
FY '20-21	16.08%	39.87%	29.03%	38.91%
FY '19-20	8.05%	-6.40%	20.67%	31.16%

Thyrocare Technologies
Shareholding Pattern

Promoters : 71.18%

FII : 12.68%

DII : 6.88%

Public : 9.26%

Others : 0%

Thyrocare Technologies
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	575.20	342.33	251.19	164.09
FY '20-21	484.44	313.44	183.35	116.46
FY '19-20	417.66	246.99	178.72	83.61

All values are in crores

Thyrocare Technologies
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
THYROCARE	575.20	342.33	251.19	164.09
VIJAYA	459.22	277.20	196.18	85.21
METROPOLIS	1,172.73	843.74	345.81	203.46

All values are in crores

Thyrocare Technologies Share Price

Thyrocare Technologies Limited is an Indian healthcare provider. The company has a Centralized Processing Laboratory (CPL) in Mumbai, India for esoteric testing and a regional processing laboratory in major cities in India and the rest of Asia. The company offers technologies such as chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), capillary electrophoresis (CE), ion-selective electrodes (ISE), fluorescent flow cytometry, nephelometry, liquid photometry, chromatography mass spectrometry (LC-MS). , inductively coupled plasma mass spectrometry (ICP-MS) and cytogenetics. The company offers various tests such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. It also offers thyroxine (T4), triiodothyronine (T3), thyroid stimulating hormone and complete vitamin profile tests.

Thyrocare Technologies FAQs

How to Buy Thyrocare Technologies Share?

To purchase Thyrocare Technologies shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Thyrocare Technologies (ticker symbol: THYROCARE) on the trading platform provided by your broker and purchase the shares.

What's Thyrocare Technologies share price today?

The stock price of Thyrocare Technologies as of 07 Sep 2024 is ₹846.62

What is the Market Cap of Thyrocare Technologies?

Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Sep 2024, Thyrocare Technologies (ticker symbol: THYROCARE) has a market capitalisation of approximately ₹30,26,01,05,583.10

What is the PE and PB ratio of Thyrocare Technologies?

Thyrocare Technologies Ltd's price-to-book ratio as of 07 Sep 2024 is 7.8686414, reflecting the market's valuation compared to its asset value. As of 07 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 25.084103, indicating the market values the company at around ₹25.08 for every ₹1 of earnings